Dl-3-n-butylphthalide effect in treatement of acute cerebral infarction

doi:10.3969/j.issn.1004-583X.2016.02.011

Abstract

CLC Number:

R743.33

Sun Yuanyuan,Li Hui,Lang Wenjuan,Feng Jiachun. Dl-3-n-butylphthalide effect in treatement of acute cerebral infarction[J]. Clinical Focus, 2016, 31(2): 182-186.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.02.011

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I2/182

[1] Wang YJ, Liao XL, Zhao XQ, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese national Stroke Registry (CNSR) [J].Stroke, 2011, 42(6):1658-1664.
[2] 梁庆. 脑梗死缺血/再灌注损伤机制的研究进展[J]. 医学理论与实践,2014,20(24):3263-3266.
[3] Mizuho N, Takeshi U, Ryotaro S, et al. Toxic acrolein production due to Ca²⁺ influx by the NMDA receptor during stroke[J]. Atherosclerosis, 2016, 244:131-137.
[4] Astrup J, Symon L, Branston NM, et al. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.[J]. Stroke, 1977,8(1):51-57.
[5] Demyanenko SV, Panchenko SN, Uzdensky AB. Expression of neuronal and signaling proteins in penumbra around a photothrombotic infarction core in rat cerebral cortex[J]. Biochemistry, 2015, 80(6):790-799.
[6] 徐皓亮, 冯亦璞. 丁基苯酞对局灶性脑缺血大鼠软脑膜微循环障碍的影响[J]. 药学学报, 1999, 34(3):172-175.
[7] 刘佳.丁苯酞对急性脑梗死患者脑血流量的影响及临床疗效观察[D].长春:吉林大学,2008:1-71.
[8] 张培蕾, 鲁海涛, 朱悦奇,等.丁苯酞对大鼠局灶性脑缺血再灌注损伤的保护作用[J]. 介入放射学杂志, 2012, 21(3):239-242.
[9] 曹文英,德吉曲宗,李其富,等. 丁基苯酞对大鼠短暂性缺血脑组织VEGF及bFGF表达的影响[J]. 四川大学学报:医学版,2009, 40(3):403-407.
[10] Lu XL, Luo D, Yao XL, et al. dl-3n-Butylphthalide promotes angiogenesis via the extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase/Akt-endothelial nitric oxide synthase signaling pathways[J]. J Cardiovasc Pharmacol, 2012, 59(4):352-362.
[11] Liu CL, Liao SJ, Zeng JS, et al. dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP[J]. J Neurol Sci, 2007,260(1/2):106-113.
[12] 李和平, 吴丽娥. 丁苯酞对急性缺血性脑卒中的作用及保护机制[J]. 中华脑血管病杂志:电子版, 2014,7(6):342-345.
[13] Kinnally KW, Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis[J]. Apoptosis, 2007, 12(5):857-868.
[14] Li J, Yin L, Ogle M, et al. DL-3-n-butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway[J]. Brain Res, 2010, 1359:216-226.
[15] Narita M, Shimizu S, Ito T, et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria[J]. Proc Natl Acad Sci U S A, 1998, 95(25):14681-14686.
[16] Bo S, Feng M, Tian X, et al. dl-3-n-Butylphthalide protects rat bone marrow stem cells against hydrogen peroxide-induced cell death through antioxidation and activation of PI3K-Akt pathway[J]. Neurosci Lett, 2012, 516(2):247-252.
[17] 葛宇松, 刘雪松, 薛俊燕,等. 丁苯酞注射液预处理通过PI3K/Akt通路对大鼠脑缺血再灌注损伤的神经保护作用[J]. 中风与神经疾病杂志,2013, 30(1): 32-36.
[18] 马荣花.丁苯酞对急性缺血性脑卒中的保护作用[J]. 脑与神经疾病杂志,2014,22(3):217-218.
[19] 张俊, 王兰琴, 王虎,等. 丁苯酞注射液对急性脑梗死患者神经功能及脂质过氧化的影响[J]. 中国实用神经疾病杂志, 2014,17(6):83-84.
[20] 胡盾,黄新祥,冯亦璞.丁基苯酞对全脑缺血大鼠的纹状体细胞外液嘌呤类代谢物含量的影响[J].药学学报,1996,31(l):13-17.
[21] Huang JZ, Cheng YZ, Su M, et al. dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease.[J]. Neurosci Lett,2010,475(2):89-94.
[22] 徐皓亮, 冯亦璞.丁基苯酞对低氧-复氧及细胞因子诱导的内皮细胞损伤及中性粒细胞粘附的影响[J]. 中国药理学与毒理学杂志,1999,13(4):172-175.
[23] 李皓.丁苯酞注射液预处理通过NF-κB信号通路对大鼠脑缺血再灌注损伤的保护作用[D]. 大连:大连医科大学, 2014:1-46.
[24] Chong ZZ, Feng YP. Effects of dl-3-n-butylphthalide on production of TXB2 and 6-keto-PGF1 alpha in rat brain during focal cerebral ischemia and reperfusion[J]. Zhongguo Yao Li Xue Bao,1997,18(6):505-508.
[25] Wang HM, Zhang T, Huang JK, et al. 3-N-butylphthalide (NBP) attenuates the amyloid-β-induced inflammatory responses in cultured astrocytes via the nuclear factor-Κb signaling pathway[J]. Cell Physiol Biochem, 2013, 32(1):235-242.
[26] 彭英,曾宪可,冯亦璞,等.丁基苯酞对血小板聚集抑制作用的研究[J].中国药理通讯,2003, 12(3): 75-75.
[27] Ye J, Zhai L, Zhang S, et al. dl-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase [J]. Platelets, 2015,26(8):736-744.
[28] 李静, 魏光宇. 丁苯酞对缺氧/复氧诱导大鼠皮层神经元损伤的保护作用[J]. 山西医科大学学报, 2010,41(1):1-3.
[29] 齐新. 丁苯酞对AMPA诱导的神经细胞损伤的保护作用及机制研究[D]. 北京:中国协和医科大学、北京协和医学院、清华大学医学部、中国医学科学院, 2008:1-80.

Dl-3-n-butylphthalide effect in treatement of acute cerebral infarction

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhang Xueqian, Li Yang, Xu Guodong, Lyu Peiyuan. Analysis of demographic, clinical and imaging in patients with acute cerebral infarction caused by patent foramen ovale [J]. Clinical Focus, 2023, 38(6): 500-503.
[2]	Wang Yingnan, Zhao Qi, Bai Haiwei, Wu Danna, Wei Jinmei, Li Shengjiang, Li Ruiling, Zhang Ruixing. Clinical characteristics and risk factors of gastric cancer-related stroke [J]. Clinical Focus, 2023, 38(5): 417-422.
[3]	Gong Tao, Hu Yueyuan, Gao Yun, Guo Chang, Shen Huinan, Wang Dongyu. Relationship between H-type hypertension and severity of neurological deficit in early acute cerebral infarction of LAA [J]. Clinical Focus, 2021, 36(7): 612-615.
[4]	Liu Zhongqiu, Chu Jianfeng. Efficacy of Ureklin combined with Alteplase for acute cerebral infarction and its influence on nerve function and inflammatory factors [J]. Clinical Focus, 2021, 36(6): 509-512.
[5]	Wang Jun, Xiao Kejin, Gao Zhaoyu, Zhu Shenghua, Zhou Yi, Liu Xiaoyu, Cai Chaoqun. Short-term clinical efficacy and prognosis of recombinant tissue plasminogen activator in anterior-posterior circulation acute ischemic stroke [J]. Clinical Focus, 2021, 36(5): 421-424.
[6]	Chen Guangpeng, Miao Guoyin, Yang Yanqin. Relationship between expression of serum vascular endothelial growth factor, procalcitonin, high-sensitivity C-reactive protein and severity of cerebral edema in patients with acute cerebral infarction [J]. Clinical Focus, 2021, 36(4): 315-318.
[7]	Zhao Yang, Ma Liang, Zhong Qigang. Effects of Guhong injection combined with salvianolate on neurological function and hemorheology in patients with acute cerebral infarction [J]. Clinical Focus, 2021, 36(3): 212-215.
[8]	Gong Tao, Gao Yun, Hu Yueyuan, Wang Dongyu. Relationship between homocysteine and early neurological impairment severity and prognosis of acute cerebral infarction [J]. Clinical Focus, 2021, 36(1): 35-38.
[9]	Lin Na, Liu Chuan, Wu Tianyu, Cao Lei. A case of acute hemorrhagic cerebral infarction caused by infective endocarditis [J]. Clinical Focus, 2021, 36(1): 66-69.
[10]	Peng Cheng1, Zhang Yuanxin1, Lin Guiying1, Lu Xiaoliang2. Relationship between serum uric acid level and prognosis of acute ischemic stroke: a metaanalysis [J]. Clinical Focus, 2020, 35(8): 677-683.
[11]	Liu Manzhuo, Wang Hui, Zhao Suxia, Wang Jing. Effects of ureklin combined with atorvastatin on clinical efficacy, ox-LDL and hs-CRP in patients with acute cerebral infarction [J]. Clinical Focus, 2020, 35(11): 1001-1004.
[12]	Xu Lihua, Wang Yongjun, Gao Suying, Yu Kai, Yang Hongna, He Yan, Geng Song. Risk factors for oneyear poor prognosis in acute cerebral infarction patients [J]. Clinical Focus, 2020, 35(10): 895-899.
[13]	Huang Debo, Lin Chuanhang, Zhou Yuanfang, Mao Xianquan, Xu Fuguan. Analysis of prognostic factors of mechanical thrombectomy in patients with acute aortic occlusive cerebral infarction [J]. Clinical Focus, 2020, 35(1): 41-46.
[14]	Huang Debo, Mao Xianquan, Xu Zhenqiang, Feng Guokuan, Xu Fuguan, He Yuyan. Clinical efficacy of mechanical thrombectomy and intravenous thrombolysis to acute aortic occlusive stroke [J]. Clinical Focus, 2019, 34(7): 617-621.
[15]	Guo Zhengliang, Xin Xiaoyu, Zeng Lili, Fu Yi. Correlation study of serum uric acid on shortterm outcome in acute ischemic stroke patients treated with intravenous recombinant tissue plasminogen activator [J]. Clinical Focus, 2019, 34(5): 416-419.